2023 annual financial data
Lexaria Bioscience 2023 Financial results
Direct answer
Revenue was 226,208 USD.
Operating income was -6,534,022 USD and net income was -6,664,899 USD.
Operating cash flow was -5,881,237 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 226,208 USD
- Operating income
- -6,534,022 USD
- Net income
- -6,664,899 USD
- Operating cash flow
- -5,881,237 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Lexaria Bioscience financial years